NCT07820397

Brief Summary

This study will evaluate and compare the quality of adipose (fat) tissue harvested using different liposuction technologies and aspiration methods. Each participant will serve as their own control, with paired fat samples collected from anatomically matched treatment areas. The study will evaluate adipocyte viability and other characteristics of the harvested tissue, including viable adipocyte density, stromal vascular fraction, metabolic activity, and fat composition. The goal of the study is to better understand how different liposuction technologies and aspiration methods affect the quality and characteristics of harvested adipose tissue.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
7mo left

Started Aug 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress22%
Aug 2026Apr 2027

Study Start

First participant enrolled

August 6, 2026

Completed
28 days until next milestone

First Submitted

Initial submission to the registry

September 3, 2026

Completed
12 days until next milestone

First Posted

Study publicly available on registry

September 15, 2026

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2027

Last Updated

September 15, 2026

Status Verified

September 1, 2026

Enrollment Period

5 months

First QC Date

September 3, 2026

Last Update Submit

September 9, 2026

Conditions

Keywords

Adipose tissueAdipose tissue viabilityFat harvestLiposuctionUltrasound-assisted liposuctionPower-assisted liposuctionAspiration modalityVASERAYONStromal vascular fractionMetabolic activityFat compositionWithin-subject comparisonPaired samples

Outcome Measures

Primary Outcomes (2)

  • Paired Difference in Adipocyte Viability Between AYON and VASER

    Adipocyte viability (%) will be assessed using membrane integrity (live/dead) analysis by Trypan Blue exclusion. The primary analysis will evaluate the paired difference in adipocyte viability between AYON ultrasound-assisted liposuction and VASER across paired adipose tissue samples.

    Day 1

  • Paired Difference in Adipocyte Viability Between Vacuum and Peristaltic Pump Aspiration

    Adipocyte viability (%) will be assessed using membrane integrity (live/dead) analysis by Trypan Blue exclusion. The primary analysis will evaluate the paired difference in adipocyte viability between vacuum and peristaltic pump aspiration across paired adipose tissue samples in the power-assisted liposuction arm.

    Day 1

Secondary Outcomes (6)

  • Viable adipocyte density (cells/mL)

    Day 1

  • Fat composition analysis

    Day 1

  • SVF yield (cells/g fat)

    Day 1

  • Metabolic activity

    Day 1

  • Aspiration rate (mL/min) (Arm 2 only)

    Day 1

  • +1 more secondary outcomes

Study Arms (2)

Ultrasound-Assisted Liposuction Comparison

ACTIVE COMPARATOR

AYON ultrasound-assisted liposuction (UAL) is compared with VASER ultrasound-assisted liposuction using paired adipose tissue samples collected from anatomically matched treatment areas. The primary outcome is the paired difference in adipocyte viability, with additional evaluation of adipose tissue characteristics.

Device: AYON Ultrasound-Assisted Liposuction SystemDevice: VASER Ultrasound-Assisted Liposuction System

Aspiration Modality Comparison

ACTIVE COMPARATOR

AYON power-assisted liposuction (PL) using a peristaltic pump is compared with vacuum aspiration using paired adipose tissue samples collected from anatomically matched treatment areas. The primary outcome is the paired difference in adipocyte viability, with additional exploratory evaluation of adipose tissue characteristics.

Device: AYON Power-Assisted Liposuction SystemDevice: Vacuum Aspiration

Interventions

Ultrasound-assisted liposuction using the AYON UAL system. In this arm, AYON UAL is compared with VASER ultrasound-assisted liposuction using paired adipose tissue samples collected from anatomically matched treatment areas. Study-specific UAL settings and treatment parameters are defined by the protocol.

Also known as: AYON UAL System, AYON
Ultrasound-Assisted Liposuction Comparison

Ultrasound-assisted liposuction using the VASER system. In this arm, VASER is compared with AYON ultrasound-assisted liposuction using paired adipose tissue samples collected from anatomically matched treatment areas. Study-specific UAL settings and treatment parameters are defined by the protocol.

Also known as: VASER
Ultrasound-Assisted Liposuction Comparison

Power-assisted liposuction using the AYON PL system with a peristaltic pump. In this arm, the peristaltic pump aspiration modality is compared with vacuum aspiration using paired adipose tissue samples collected from anatomically matched treatment areas.

Also known as: AYON PL, AYON PL System
Aspiration Modality Comparison

Vacuum aspiration used for adipose tissue harvest in the power-assisted liposuction comparison. In this arm, vacuum aspiration is compared with AYON power-assisted liposuction using a peristaltic pump through paired adipose tissue samples collected from anatomically matched treatment areas.

Aspiration Modality Comparison

Eligibility Criteria

Age30 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male or female aged 30 to 65 years, inclusive.
  • Planned elective liposuction/body contouring procedure involving two or more anatomical areas (e.g., arms, abdomen, flanks, thighs, and/or back) with sufficient distribution to permit collection of paired adipose tissue samples from contralateral or anatomically matched treatment areas.
  • Investigator determines the subject is an appropriate candidate for the planned procedure and study participation.
  • Adequate adipose tissue is present to permit collection of required paired fat samples without impacting the planned surgical outcome.
  • Able to understand and sign the informed consent form.
  • Willing and able to comply with study requirements.
  • If applicable, female subjects of childbearing potential must have a negative urine pregnancy test on the day of procedure.

You may not qualify if:

  • Prior liposuction or surgical intervention in the planned treatment areas that, in the opinion of the investigator, may affect adipose tissue characteristics or study assessments.
  • Prior treatment of the planned treatment areas with energy-based devices (e.g., ultrasound, radiofrequency, laser) that, in the opinion of the investigator, may affect adipose tissue characteristics or study assessments.
  • Significant skin laxity, fibrosis, scarring, or other abnormal tissue characteristics in the planned treatment areas that could impact fat harvest quality or comparability between sites.
  • Current smoker or use of nicotine-containing products within 4 weeks prior to the procedure.
  • Known metabolic or systemic conditions that may affect adipose tissue biology or wound healing, including but not limited to:
  • uncontrolled diabetes mellitus
  • significant vascular disease
  • connective tissue disorders
  • Use of medications known to significantly affect fat metabolism, tissue healing, or inflammatory response, including:
  • chronic systemic corticosteroids
  • immunosuppressive therapies
  • GLP-1 receptor agonists (e.g., semaglutide, tirzepatide) within 4 weeks prior to the procedure
  • Active local or systemic infection at the time of the procedure.
  • Known coagulopathy or use of anticoagulant therapy that cannot be safely discontinued prior to surgery.
  • Pregnant or breastfeeding subjects.
  • +4 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Mentor Plastic Surgery

Concord, Ohio, 44077, United States

RECRUITING

Pearl Plastic Surgery

Olympia, Washington, 98506, United States

RECRUITING

Related Publications (22)

  • Pu LL. Mechanisms of Fat Graft Survival. Ann Plast Surg. 2016 Feb;77 Suppl 1:S84-6. doi: 10.1097/SAP.0000000000000730.

    PMID: 26808753BACKGROUND
  • Fontes T, Brandao I, Negrao R, Martins MJ, Monteiro R. Autologous fat grafting: Harvesting techniques. Ann Med Surg (Lond). 2018 Nov 13;36:212-218. doi: 10.1016/j.amsu.2018.11.005. eCollection 2018 Dec.

    PMID: 30505441BACKGROUND
  • Mojallal A, Auxenfans C, Lequeux C, Braye F, Damour O. Influence of negative pressure when harvesting adipose tissue on cell yield of the stromal-vascular fraction. Biomed Mater Eng. 2008;18(4-5):193-7.

    PMID: 19065021BACKGROUND
  • Yoshimura K, Suga H, Eto H. Adipose-derived stem/progenitor cells: roles in adipose tissue remodeling and potential use for soft tissue augmentation. Regen Med. 2009 Mar;4(2):265-73. doi: 10.2217/17460751.4.2.265.

    PMID: 19317645BACKGROUND
  • Molitor M, Travnickova M, Mestak O, Christodoulou P, Sedlar A, Bacakova L, Lucchina S. The Influence of High and Low Negative Pressure Liposuction and Various Harvesting Techniques on the Viability and Function of Harvested Cells-a Systematic Review of Animal and Human Studies. Aesthetic Plast Surg. 2021 Oct;45(5):2379-2394. doi: 10.1007/s00266-021-02249-9. Epub 2021 Apr 19.

    PMID: 33876289BACKGROUND
  • Coleman SR. Structural fat grafting: more than a permanent filler. Plast Reconstr Surg. 2006 Sep;118(3 Suppl):108S-120S. doi: 10.1097/01.prs.0000234610.81672.e7.

    PMID: 16936550BACKGROUND
  • Fisher C, Grahovac TL, Schafer ME, Shippert RD, Marra KG, Rubin JP. Comparison of harvest and processing techniques for fat grafting and adipose stem cell isolation. Plast Reconstr Surg. 2013 Aug;132(2):351-361. doi: 10.1097/PRS.0b013e3182958796.

    PMID: 23584621BACKGROUND
  • Shiffman MA, Mirrafati S. Fat transfer techniques: the effect of harvest and transfer methods on adipocyte viability and review of the literature. Dermatol Surg. 2001 Sep;27(9):819-26. doi: 10.1046/j.1524-4725.2001.01062.x.

    PMID: 11553171BACKGROUND
  • Eto H, Suga H, Matsumoto D, Inoue K, Aoi N, Kato H, Araki J, Yoshimura K. Characterization of structure and cellular components of aspirated and excised adipose tissue. Plast Reconstr Surg. 2009 Oct;124(4):1087-1097. doi: 10.1097/PRS.0b013e3181b5a3f1.

    PMID: 19935292BACKGROUND
  • Kurita M, Matsumoto D, Shigeura T, Sato K, Gonda K, Harii K, Yoshimura K. Influences of centrifugation on cells and tissues in liposuction aspirates: optimized centrifugation for lipotransfer and cell isolation. Plast Reconstr Surg. 2008 Mar;121(3):1033-1041. doi: 10.1097/01.prs.0000299384.53131.87.

    PMID: 18317153BACKGROUND
  • Rohrich RJ, Sorokin ES, Brown SA. In search of improved fat transfer viability: a quantitative analysis of the role of centrifugation and harvest site. Plast Reconstr Surg. 2004 Jan;113(1):391-5; discussion 396-7. doi: 10.1097/01.PRS.0000097293.56504.00.

    PMID: 14707664BACKGROUND
  • Shauly O, Gould DJ, Ghavami A. Fat Grafting: Basic Science, Techniques, and Patient Management. Plast Reconstr Surg Glob Open. 2022 Mar 18;10(3):e3987. doi: 10.1097/GOX.0000000000003987. eCollection 2022 Mar.

    PMID: 35317456BACKGROUND
  • Ruff PG 4th, Garcia O Jr, Nykiel MJ, Galanis CJ. Consensus-based Recommendations for Vibration Amplification of Sound Energy at Resonance Ultrasound-assisted Liposuction. Plast Reconstr Surg Glob Open. 2023 Jul 11;11(7):e5110. doi: 10.1097/GOX.0000000000005110. eCollection 2023 Jul.

    PMID: 37441115BACKGROUND
  • Cimino WW. Ultrasonic surgery: power quantification and efficiency optimization. Aesthet Surg J. 2001 May;21(3):233-41. doi: 10.1067/maj.2001.116006.

    PMID: 19331898BACKGROUND
  • Kloehn RA. Liposuction With "Sonic Sculpture": Six Years' Experience With More Than 600 Patients. Aesthetic Surgery Journal. 1996/01/01/ 1996;16(2):123-128

    BACKGROUND
  • Beckenstein MS, Grotting JC. Ultrasound-assisted lipectomy using the solid probe: a retrospective review of 100 consecutive cases. Plast Reconstr Surg. 2000 May;105(6):2161-74; discussion 2175-9. doi: 10.1097/00006534-200005000-00041.

    PMID: 10839419BACKGROUND
  • Lawrence N, Coleman WP 3rd. The biologic basis of ultrasonic liposuction. Dermatol Surg. 1997 Dec;23(12):1197-200. doi: 10.1111/j.1524-4725.1997.tb00474.x.

    PMID: 9426668BACKGROUND
  • Garcia O. Ultrasound-Assisted Liposuction Current Concepts and Techniques: Current Concepts and Techniques. 2020.

    BACKGROUND
  • Jewell ML. Ultrasonic-Assisted Liposuction: Introduction and Historic Perspectives. In: Garcia Jr O, ed. Ultrasound-Assisted Liposuction: Current Concepts and Techniques; Springer International Publishing date 2020; pages 3-8.

    BACKGROUND
  • Jewell ML, Fodor PB, de Souza Pinto EB, Al Shammari MA. Clinical application of VASER--assisted lipoplasty: a pilot clinical study. Aesthet Surg J. 2002 Mar;22(2):131-46. doi: 10.1067/maj.2002.123377.

    PMID: 19331963BACKGROUND
  • Chang CC, Commons GW. A comparison of various ultrasound technologies. Clin Plast Surg. 1999 Apr;26(2):261-8; viii.

  • Serdev N. Ultrasound Assisted Liposculpture UAL: A Simplified Safe Body Sculpturing and Aesthetic Beautification Technique. 2011.

    RESULT

MeSH Terms

Interventions

Vacuum Curettage

Intervention Hierarchy (Ancestors)

Dilatation and CurettageCurettageSurgical Procedures, OperativeGynecologic Surgical ProceduresUrogenital Surgical Procedures

Study Officials

  • Paul Vanek, MD

    Mentor Plastic Surgery

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Global Senior Director, Clinical Affairs

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
There is no indication in the protocol that participants, investigators/care providers, or outcome assessors are masked. The device/treatment being used is known during the procedure.
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Model Details: Participants are assigned to one of two comparison arms. Within each arm, paired adipose tissue samples are collected from anatomically matched treatment areas, with each participant serving as their own control.
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 3, 2026

First Posted

September 15, 2026

Study Start

August 6, 2026

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

April 30, 2027

Last Updated

September 15, 2026

Record last verified: 2026-09

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared with other researchers. Study results will be reported in aggregate.

Locations